Cannabidiol in the Treatment of Opioid Use Disorder

NCT06206291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Placebo
DRUG: Cannabidiol (CBD) 200mg
DRUG: Cannabidiol (CBD) 400mg

Sponsor

Yasmin Hurd